title: A new roadmap for drug development for Alzheimer's disease.
authors.affiliation: Aristea Translational Medicine, 5011 Mountain View Road #63, Carrabassett Valley, Maine O4947, USA, and a Clinical Consultant in the Drug Design and Development Section, Translational Gerontology Branch, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, Maryland 21224, USA.
authors.forename: Robert E
authors.initials: RE
authors.lastname: Becker
authors.affiliation: Drug Design and Development Section, Translational Gerontology Branch, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore Maryland 21224, USA.
authors.forename: Nigel H
authors.initials: NH
authors.lastname: Greig
authors.affiliation: Department of Internal Medicine, Rehabilitation, and Geriatrics, University of Geneva, Medical School, University Hospitals of Geneva, Thonex-Geneva, Switzerland.
authors.forename: Ezio
authors.initials: E
authors.lastname: Giacobini
authors.affiliation: Departments of Psychiatry, Neurology, and Gerontology, Keck School of Medicine, University of Southern California, Los Angeles, California 90033, USA.
authors.forename: Lon S
authors.initials: LS
authors.lastname: Schneider
authors.affiliation: Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, Maryland 21224, USA.
authors.forename: Luigi
authors.initials: L
authors.lastname: Ferrucci
mesh_terms: D000544:Alzheimer Disease / Q000517:prevention & control*; D002986:Clinical Trials as Topic / Q000379:methods*; D006801:Humans